Prognostic significance of microRNA-141 expression and its tumor suppressor function in human pancreatic ductal adenocarcinoma

Molecular and Cellular Biochemistry

Volumn 388, Issue 1-2, 2014, Pages 39-49

  Zhu, Zi Man ^a   Xu, Yue Fang ^a   Su, Qin Jun ^b   Du, Jun Dong ^a   Tan, Xiang Long ^a   Tu, Yu Liang ^a   Tan, Jing Wang ^a   Jiao, Hua Bao ^a  

^a CHINESE PLA GENERAL HOSPITAL   (China)

^b LANZHOU GENERAL HOSPITAL   (China)

Author keywords

MicroRNA 141; Pancreatic ductal adenocarcinoma; Prognosis; YAP1

Indexed keywords

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ADENOCARCINOMA; APOPTOSIS; CARCINOMA, PANCREATIC DUCTAL; CASPASE 3; CELL LINE, TUMOR; CELL PROLIFERATION; DOWN-REGULATION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, TUMOR SUPPRESSOR; HUMANS; LYMPHATIC METASTASIS; MALE; MICRORNAS; MIDDLE AGED; PANCREAS; PANCREATIC NEOPLASMS; PHOSPHOPROTEINS; PROGNOSIS; RNA INTERFERENCE; RNA, SMALL INTERFERING;

EID: 84893854563     PISSN: 03008177     EISSN: 15734919     Source Type: Journal    
DOI: 10.1007/s11010-013-1897-y     Document Type: Article

References (34)

1. Jemal A, Siegel R, Xu J et al (2010) Cancer statistics, 2010. CA Cancer J Clin 60:277-300
2. Giovinazzo F, Turri G, Zanini S et al (2012) Clinical implications of biological markers in pancreatic ductal adenocarcinoma. Surg Oncol 21:e171-e182
3. Krautz C, Rückert F, Saeger HD et al (2011) An update on molecular research of pancreatic adenocarcinoma. Anticancer Agents Med Chem 11:411-417
4. Pasquinelli AE, Ruvkun G (2002) Control of developmental timing by micrornas and their targets. Annu Rev Cell Dev Biol 18:495-513 (Pubitemid 35387359)
5. Ke XS, Liu CM, Liu DP et al (2003) MicroRNAs: key participants in gene regulatory networks. Curr Opin Chem Biol 7:516-523 (Pubitemid 36980844)
6. Takaya T, Nishi H, Horie T et al (2012) Roles of microRNAs and myocardial cell differentiation. Prog Mol Biol Transl Sci 111:139-152
7. Sharma A, Wu JC (2013) MicroRNA expression profiling of human-induced pluripotent and embryonic stem cells. Methods Mol Biol 936:247-256
8. Jovanovic M, Hengartner MO (2006) MiRNAs and apoptosis: RNAs to die for. Oncogene 25:6176-6187 (Pubitemid 44527848)
9. Dalmay T, Edwards DR (2006) MicroRNAs and the hallmarks of cancer. Oncogene 25:6170-6175 (Pubitemid 44527847)
10. Shen J, Stass SA, Jiang F (2013) MicroRNAs as potential biomarkers in human solid tumors. Cancer Lett 329:125-136
11. Zhang L, Jamaluddin MS, Weakley SM et al (2011) Roles and mechanisms of microRNAs in pancreatic cancer. World J Surg 35:1725-1731
12. Wang J, Sen S (2011) MicroRNA functional network in pancreatic cancer: from biology to biomarkers of disease. J Biosci 36:481-491
13. Yu XY, Zhang Z, Liu J et al (2013) MicroRNA-141 is downregulated in human renal cell carcinoma and regulates cell survival by targeting CDC25B. Onco Targets Ther 6:349-354
14. Hu M, Xia M, Chen X et al (2010) MicroRNA-141 regulates Smad interacting protein 1 (SIP1) and inhibits migration and invasion of colorectal cancer cells. Dig Dis Sci 55:2365-2372
15. Du Y, Xu Y, Ding L et al (2009) Down-regulation of miR-141 in gastric cancer and its involvement in cell growth. J Gastroenterol 44:556-561
16. Zhang Z, Li Z, Gao C et al (2008) MiR-21 plays a pivotal role in gastric cancer pathogenesis and progression. Lab Invest 88:1358-1366
17. Wang R, Huang J, Feng B et al (2012) Identification of ING4 (inhibitor of growth 4) as a modulator of docetaxel sensitivity in human lung adenocarcinoma. Mol Med 18:874-886
18. Imanaka Y, Tsuchiya S, Sato F et al (2011) MicroRNA-141 confers resistance to cisplatin-induced apoptosis by targeting YAP1 in human esophageal squamous cell carcinoma. J Hum Genet 56:270-276
19. Nolan T, Cogoni C (2004) The long hand of the small RNAs reaches into several levels of gene regulation. Biochem Cell Biol 82:472-481 (Pubitemid 39286962)
20. Fernández-Hernando C, Ramírez CM, Goedeke L et al (2013) MicroRNAs in metabolic disease. Arterioscler Thromb Vasc Biol 33:178-185
21. Crippa S, Cassano M, Sampaolesi M (2012) Role of miRNAs in muscle stem cell biology: proliferation, differentiation and death. Curr Pharm Des 18:1718-1729
22. Zhang B, Pan X, Cobb GP et al (2007) MicroRNAs as oncogenes and tumor suppressors. Dev Biol 302:1-12 (Pubitemid 46096921)
23. Lee YS, Dutta A (2006) MicroRNAs: small but potent oncogenes or tumor suppressors. Curr Opin Investig Drugs 7:560-564 (Pubitemid 43891035)
24. Cheng H, Zhang L, Cogdell DE et al (2011) Circulating plasma MiR-141 is a novel biomarker for metastatic colon cancer and predicts poor prognosis. PLoS ONE 6:e17745
25. Leskelä S, Leandro-García LJ, Mendiola M et al (2010) The miR-200 family controls beta-tubulin III expression and is associated with paclitaxel-based treatment response and progression-free survival in ovarian cancer patients. Endocr Relat Cancer 18:85-95
26. Gonzales JC, Fink LM, Goodman OB Jr et al (2011) Comparison of circulating MicroRNA 141 to circulating tumor cells, lactate dehydrogenase, and prostate-specific antigen for determining treatment response in patients with metastatic prostate cancer. Clin Genitourin Cancer 9:39-45
27. Jia Y, Yang Y, Zhan Q et al (2012) Inhibition of SOX17 by microRNA 141 and methylation activates the WNT signaling pathway in esophageal cancer. J Mol Diagn 14:577-585
28. Berkers J, Govaere O, Wolter P et al (2013) A possible role for microRNA-141 down-regulation in sunitinib resistant metastatic clear cell renal cell carcinoma through induction of epithelial-to-mesenchymal transition and hypoxia resistance. J Urol 189:1930-1938
29. Sudol M, Shields DC, Farooq A (2012) Structures of YAP protein domains reveal promising targets for development of new cancer drugs. Semin Cell Dev Biol 23:827-833
30. Tschaharganeh DF, Chen X, Latzko P et al (2013) Yes-associated protein up-regulates Jagged-1 and activates the Notch pathway in human hepatocellular carcinoma. Gastroenterology 144(1530-42):e12
31. Yuan M, Tomlinson V, Lara R et al (2008) Yes-associated protein (YAP) functions as a tumor suppressor in breast. Cell Death Differ 15:1752-1759
32. Li SY, Hu JA, Wang HM (2013) Expression of Yes-associated protein 1 gene and protein in oral squamous cell carcinoma. Chin Med J (Engl) 126:655-658
33. Yeo MK, Kim SH, Kim JM et al (2012) Correlation of expression of phosphorylated and non-phosphorylated Yes-associated protein with clinicopathological parameters in esophageal squamous cell carcinoma in a Korean population. Anticancer Res 32:3835-3840
34. Diep CH, Zucker KM, Hostetter G et al (2012) Down-regulation of Yes associated protein 1 expression reduces cell proliferation and clonogenicity of pancreatic cancer cells. PLoS ONE 7:e32783